Published in Circulation on July 01, 1992
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev (2011) 5.51
Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2011) 4.72
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A (1993) 2.48
Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect (1999) 2.11
Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci U S A (1994) 1.96
Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest (1995) 1.94
Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health Care. CMAJ (1999) 1.90
Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J Physiol (1995) 1.76
Intrapulmonary arteriovenous shunting may be a universal phenomenon in patients with the superior cavopulmonary anastomosis: a radionuclide study. Heart (2000) 1.59
Catheter ablation for successful management of left posterior fascicular tachycardia: an approach guided by recording of fascicular potentials. Heart (1996) 1.47
The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression. Proc Natl Acad Sci U S A (1995) 1.47
Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest (1993) 1.45
Defining basic services and de-insuring the rest: the wrong diagnosis and the wrong prescription. CMAJ (1995) 1.39
Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ (1993) 1.38
Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J (1994) 1.37
In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A (1994) 1.29
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest (1993) 1.22
Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest (1993) 1.16
Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes. J Appl Physiol (1985) (2011) 1.14
Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene. J Clin Invest (1993) 1.13
Anticoagulation after intracoronary stent insertion. Br Heart J (1994) 1.11
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol (1996) 1.11
Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? BMJ (1994) 1.10
Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest (1994) 1.09
Cardiorespiratory fitness and coronary artery calcification in young adults: The CARDIA Study. Atherosclerosis (2008) 1.00
Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol (1994) 1.00
Systematic review of the effect of diet and exercise lifestyle interventions in the secondary prevention of coronary heart disease. Cardiol Res Pract (2010) 0.98
Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am J Pathol (1993) 0.98
Summary: workshop on health risks attributable to ETS exposure in the workplace. Environ Health Perspect (1999) 0.96
Obstructive sleep apnoea. Thorax (1993) 0.95
Downregulation of cardiac guanosine 5'-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J Clin Invest (1993) 0.95
The coronary circulation in exercise training. Am J Physiol Heart Circ Physiol (2011) 0.94
Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. Br Heart J (1995) 0.93
The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J (1994) 0.93
Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy. Heart (1996) 0.91
Mechanism of beneficial effects of physical activity on atherosclerosis and coronary heart disease. J Appl Physiol (1985) (2011) 0.91
Effect of cyclopiazonic acid, an inhibitor of sarcoplasmic reticulum Ca(2+)-ATPase, on the frequency-dependence of the contraction-relaxation cycle of the guinea-pig isolated atrium. Br J Pharmacol (1994) 0.90
Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker. Br Heart J (1995) 0.89
Primary angioplasty. Br Heart J (1995) 0.89
Effects of exercise training on coronary collateralization and control of collateral resistance. J Appl Physiol (1985) (2011) 0.89
Changes in myocardial perfusion due to physical exercise in patients with stable coronary artery disease. Eur J Nucl Med Mol Imaging (2005) 0.87
Utility of intravascular ultrasound in peripheral interventions. Tex Heart Inst J (1997) 0.87
Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br Heart J (1994) 0.86
Three dimensional reconstruction of cross sectional intracoronary ultrasound: clinical or research tool? Br Heart J (1995) 0.86
Familial dilated cardiomyopathy. Br Heart J (1994) 0.86
Coronary restenosis and gene therapy. Tex Heart Inst J (1994) 0.86
Comparison between two programmes for reducing the levels of risk indicators of heart diseases among male professional drivers. Occup Environ Med (1998) 0.85
Short-term exercise training prevents micro- and macrovascular disease following coronary stenting. J Appl Physiol (1985) (2010) 0.84
Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases. Oxid Med Cell Longev (2015) 0.83
Ca2+ sensitization and PKC contribute to exercise training-enhanced contractility in porcine collateral-dependent coronary arteries. Am J Physiol Heart Circ Physiol (2011) 0.83
Effects of exercise rehabilitation on blood pressure of patients after myocardial infarction. Int J Prev Med (2010) 0.82
New developments in the diagnosis and management of cardiac allograft vasculopathy. Tex Heart Inst J (1995) 0.80
Cardiac rehabilitation: a comprehensive review. Curr Control Trials Cardiovasc Med (2001) 0.80
Inspiratory muscle endurance in patients with chronic heart failure. Heart (1996) 0.80
Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training. Vascul Pharmacol (2012) 0.80
Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor. J Clin Invest (1993) 0.79
Management of stable angina. Postgrad Med J (2003) 0.79
Impact of stenting on coronary angioplasty procedures. Heart (1998) 0.79
The treatment of heart failure--what next? Br J Clin Pharmacol (1993) 0.78
Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. Proc Natl Acad Sci U S A (1996) 0.77
Decreasing cholesterol levels in the community--lifestyle change with statin? BMC Fam Pract (2015) 0.77
Cardiac rehabilitation, exercise training, and preventive cardiology research at Ochsner Heart and Vascular Institute. Tex Heart Inst J (1995) 0.77
Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies. Br Heart J (1994) 0.77
Benefits of exercise training on coronary blood flow in coronary artery disease patients. Prog Cardiovasc Dis (2014) 0.77
[Ambulatory cardiac phase II rehabilitation--"the Cologne model"--including 3-year-outcome after termination of rehabilitation]. Herz (1999) 0.76
Thrombin and antithrombotic therapy in interventional cardiology. Tex Heart Inst J (1994) 0.76
Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J (1994) 0.76
The renin-angiotensin-aldosterone system and cardiac ischaemia. Heart (1996) 0.76
Angiographic trials of lipid-lowering therapy: end of an era? Br Heart J (1995) 0.76
Intravascular ultrasound: an inside view. Br Heart J (1994) 0.76
Effects of diet and exercise interventions on diabetes risk factors in adults without diabetes: meta-analyses of controlled trials. Diabetol Metab Syndr (2014) 0.76
Medical treatment beyond ACE inhibition: false promise or lack of vision? Br Heart J (1994) 0.75
Autologous vein-coated stent for exclusion of a coronary artery aneurysm: case report with postimplantation intravascular ultrasound characteristics. Tex Heart Inst J (1999) 0.75
Electrocardiographic measures of ventricular repolarisation dispersion in patients with coronary artery disease susceptible to ventricular fibrillation. Heart (1998) 0.75
Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa. Clin Exp Immunol (1994) 0.75
Walking and Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study. Arterioscler Thromb Vasc Biol (2016) 0.75
Aging and the heart. West J Med (1993) 0.75
Exercise Lowers Plasma Angiopoietin-Like 2 in Men with Post-Acute Coronary Syndrome. PLoS One (2016) 0.75
Impact of exercise-based cardiac rehabilitation on de novo coronary lesion in patients with drug eluting stent. Ann Rehabil Med (2014) 0.75
The arterial thrombotic process and emerging drugs for its control. Tex Heart Inst J (1993) 0.75
Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. Heart (1996) 0.75
Intracoronary ultrasound. Postgrad Med J (1998) 0.75
Perinodal slow potential as a local guide for transcatheter radiofrequency ablation of atrioventricular nodal reentrant tachycardia: therapeutic efficacy and electrophysiological mechanisms of success. Br Heart J (1995) 0.75
Radiofrequency catheter ablation: a new frontier in interventional cardiology. Br Heart J (1994) 0.75
Recent advances in the treatment of acute myocardial infarction. Tex Heart Inst J (1995) 0.75
Non-invasive assessment of atherosclerotic coronary lesion length using multidetector computed tomography angiography: comparison to quantitative coronary angiography. Int J Cardiovasc Imaging (2012) 0.75
Molecular genetic aspects of the Romano-Ward long QT syndrome. Tex Heart Inst J (1994) 0.75
Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition. Br Heart J (1994) 0.75
Treatment of end stage dilated cardiomyopathy. Br Heart J (1994) 0.75
Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance. Br Heart J (1994) 0.75
Peripheral circulatory adaptations to pump failure of the heart. Br Heart J (1994) 0.75
Non-smoke spontaneous contrast in left atrium intensified by respiratory manoeuvres: a new transoesophageal echocardiographic observation. Br Heart J (1994) 0.75
The Contribution of Individual Exercise Training Components to Clinical Outcomes in Randomised Controlled Trials of Cardiac Rehabilitation: A Systematic Review and Meta-regression. Sports Med Open (2017) 0.75
Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem (1991) 4.45
Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem (1991) 4.34
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90
Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int (1998) 2.45
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res (1999) 2.12
Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol (1995) 2.11
Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell (1995) 2.10
Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol (1993) 2.10
Exercise training for rehabilitation and secondary prevention of falls in geriatric patients with a history of injurious falls. J Am Geriatr Soc (2001) 1.82
Isotope and temperature effects in liquid water probed by x-ray absorption and resonant x-ray emission spectroscopy. Phys Rev Lett (2008) 1.75
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol (2001) 1.71
Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci U S A (1997) 1.68
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev (2000) 1.62
The mechanism of the oxidation of ascorbate and MN2+ by chloroplasts. The role of the radical superoxide. Biochim Biophys Acta (1973) 1.55
Dinitrophenol as an uncoupler of photosynthetic phosphorylation. Biochem Biophys Res Commun (1964) 1.54
In vivo analysis of the murine beta-myosin heavy chain gene promoter. J Biol Chem (1993) 1.50
Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise. Circulation (1997) 1.48
Blood pressure and adipose tissue linoleic acid. Res Exp Med (Berl) (1979) 1.46
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer. Gut (1988) 1.40
Functional nuclear organization of transcription and DNA replication: a topographical marriage between chromatin domains and the interchromatin compartment. Cold Spring Harb Symp Quant Biol (2011) 1.38
Distance to achieve steady state walking speed in frail elderly persons. Gait Posture (2007) 1.37
Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol (1996) 1.37
Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis. J Clin Invest (1973) 1.36
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem (1995) 1.34
Secondary prevention through cardiac rehabilitation: position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur Heart J (2003) 1.32
Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol (1997) 1.31
Evaluation of the incidental and planned activity questionnaire (IPEQ) for older people. Br J Sports Med (2009) 1.30
Single dose treatment with H2 receptor antagonists: is bedtime administration too late? Gut (1987) 1.29
Transgenic analysis of the thyroid-responsive elements in the alpha-cardiac myosin heavy chain gene promoter. J Biol Chem (1993) 1.29
A randomized trial of comprehensive geriatric assessment and home intervention in the care of hospitalized patients. Age Ageing (1999) 1.27
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
[Prevalence of Gilbert's syndrome in Germany]. Dtsch Med Wochenschr (1987) 1.23
Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardiol (2001) 1.23
Localization of photophosphorylation and proton transport activities in various regions of the chloroplast lamellae. Biochim Biophys Acta (1971) 1.22
Exercise training in coronary artery disease and coronary vasomotion. Circulation (2001) 1.21
Two sites for adenosine triphosphate formation in photosynthetic electron transport mediated by photosystem I. Evidence from digitonin subchloroplast particles. Biochemistry (1971) 1.21
Photosynthetic Reactions in the Marine Alga Codium vermilara: I. CO(2) Fixation and Hill Reaction in Isolated Chloroplasts. Plant Physiol (1973) 1.20
Confocal Raman-spectroscopy: analytical approach to solid dispersions and mapping of drugs. Pharm Res (1999) 1.16
Stimulation of photoreactions of isolated chloroplasts by serum albumin. Plant Physiol (1968) 1.16
Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients. Aliment Pharmacol Ther (1987) 1.16
Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem (2000) 1.15
Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol (1992) 1.15
Ptychographic coherent x-ray diffractive imaging in the water window. Opt Express (2011) 1.14
Uncoupling photophosphorylation by detergents. Biochim Biophys Acta (1965) 1.14
[Traumatic pseudoaneurysm of arteria femoralis profunda--the case report]. Rozhl Chir (2007) 1.12
Mechanisms of beta-adrenergic stimulation of cardiac Ca2+ channels revealed by discrete-time Markov analysis of slow gating. Biophys J (1993) 1.11
Prospective value of self-report and performance-based tests of functional status for 18-month outcomes in elderly patients. Aging (Milano) (1996) 1.10
Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol (1999) 1.09
Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation (2001) 1.09
[The German version of the Falls Efficacy Scale-International Version (FES-I)]. Z Gerontol Geriatr (2006) 1.08
On-line detection of nonspecific protein adsorption at artificial surfaces. Anal Chem (1997) 1.08
Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species. J Mol Cell Cardiol (1999) 1.08
Photophosphorylation in digitonin subchloroplast particles. Absence of a light-induced pH shift. J Biol Chem (1970) 1.08
Recommendations for promoting the engagement of older people in activities to prevent falls. Qual Saf Health Care (2007) 1.07
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. Br J Cancer (2012) 1.07
Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology (1995) 1.06
Human fat cell adenylate cyclase: regional differences in adrenaline responsiveness. Eur J Clin Invest (1977) 1.06
Evidence for presence and hormonal regulation of protein phosphatase inhibitor-1 in ventricular cardiomyocyte. Am J Physiol (1996) 1.05
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04
[Palliative geriatrics. What are the differences between oncologic and non-oncologic palliative geriatric inpatients?]. Z Gerontol Geriatr (2010) 1.04
Antimycin A as an uncoupler and electron transport inhibitor in photoreactions of chloroplasts. Biochim Biophys Acta (1969) 1.03
Plasma cystine concentration and redox state in aging and physical exercise. Mech Ageing Dev (2002) 1.03
Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.02
In vivo regulation of the mouse beta myosin heavy chain gene. J Biol Chem (1994) 1.01
Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil (2003) 1.01
Single-stage revision for peri-prosthetic shoulder infection: outcomes and results. Bone Joint J (2013) 1.00
Silent myocardial ischemia as a potential link between lack of premonitoring symptoms and increased risk of cardiac arrest during physical stress. Am J Cardiol (1990) 1.00
Opposite effect of cAMP signaling in endothelial barriers of different origin. Am J Physiol Cell Physiol (2004) 1.00
The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: an analysis of the AIO KRK-0104-trial. Int J Cancer (2011) 0.99
Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. J Neurosurg (1996) 0.99
Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection. J Clin Microbiol (1989) 0.99
M2-specific muscarinic cholinergic receptor-mediated inhibition of cardiac regulatory protein phosphorylation. Am J Physiol (1994) 0.98
Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation (1997) 0.98
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant (2000) 0.98
Regional expression of phospholamban in the human heart. Cardiovasc Res (1999) 0.98
Proton conductance of the thylakoid membrane: modulation by light. FEBS Lett (1977) 0.98
Identification and characterization of diadenosine 5',5"'-P1,P2 -diphosphate and diadenosine 5',5"'-P1,P3-triphosphate in human myocardial tissue. FASEB J (1999) 0.97
Photosynthetic phosphorylation in Chlamydomonas reinhardi. Effects of a mutation altering and ATP-synthesizing enzyme. Biochim Biophys Acta (1971) 0.97
Drug-prescribing patterns in old age. A study of the impact of hospitalization on drug prescriptions and follow-up survey in patients 75 years and older. Eur J Clin Pharmacol (1991) 0.97
Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.97
Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR. Part II. Eur J Prev Cardiol (2012) 0.96
Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts. Mol Cell Biochem (1996) 0.96
Adrenergic regulation of lipolysis in abdominal adipocytes of obese subjects during caloric restriction: reversal of catecholamine action caused by relief of endogenous inhibition. Eur J Clin Invest (1985) 0.96
Development of a standard fall data format for signals from body-worn sensors : the FARSEEING consensus. Z Gerontol Geriatr (2013) 0.95